Literature DB >> 7053257

Phase II trial of mitolactol in patients with metastatic melanoma.

W Medina, J M Kirkwood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7053257

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  1 in total

1.  Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma.

Authors:  D A Amato; H Bruckner; D Guerry; A Ash; G Falkson; E C Borden; R H Creech; E D Savlov; T J Cunningham
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.